Primary Angiitis of the Central Nervous System (PACNS): A Patient Guide

Primary Angiitis of the Central Nervous System (PACNS)—historically and sometimes still referred to as Granulomatous Angiitis—is an exceptionally rare condition where the body’s immune system mistakenly attacks the blood vessels within the brain and spinal cord ^[1]. Unlike other forms of “systemic” vasculitis that can affect the lungs or kidneys, this disease is strictly isolated to the central nervous system, meaning the inflammation is confined to the delicate vessels of the brain, its protective layers, and the spine ^[2]. Because these vessels provide life-sustaining oxygen to brain tissue, the resulting inflammation—known as transmural inflammation—can narrow or block blood flow, leading to a wide range of neurological challenges ^[3].

The way this condition shows up varies significantly from person to person, often making the road to diagnosis feel like a medical mystery. Some people experience a gradual, “insidious” onset of persistent headaches, memory loss, or subtle changes in personality, while others may experience sudden strokes, “mini-strokes” (TIAs), or new-onset seizures ^[4][5]. Because these symptoms overlap with many more common conditions like infections or tumors, doctors must act as detectives to rule out “mimics.” This diagnostic process involves a careful integration of findings. While a brain biopsy is the most specific test to examine the vessel walls directly under a microscope and confirm the pattern of inflammation, doctors will also carefully synthesize MRI, spinal fluid, and angiogram results, especially when biopsy is not safe or possible ^[3][6].

Living with a diagnosis of PACNS requires a dedicated, multidisciplinary team of specialists, typically including neurologists and rheumatologists, who work together to quiet the immune system. Treatment is generally divided into two stages: an intensive induction phase to stop active damage using high-dose steroids and potent immunosuppressants (like cyclophosphamide or rituximab), followed by a long-term maintenance phase to keep the disease in remission ^[7][8]. Because these medications are powerful, rigorous safety monitoring for infections and organ function is essential. Furthermore, because the risk of the disease returning, or relapsing, is relatively high, patients remain under close watch with regular neurological exams and specialized imaging like vessel-wall MRI ^[9][10].

While a diagnosis of such a rare condition is undoubtedly life-altering, the focus of modern care is to protect brain function and maximize quality of life. Many patients achieve successful remission and regain independence, even if they must navigate some lasting symptoms or the need for chronic monitoring. By working closely with an expert team, understanding safety protocols, and staying vigilant for new symptoms, you can take an active role in managing this condition and moving toward a stable, long-term recovery ^[11][12].